Reuters logo
BRIEF-Antares Pharma reports Q1 loss per share $0.03
May 9, 2017 / 11:08 AM / 5 months ago

BRIEF-Antares Pharma reports Q1 loss per share $0.03

May 9 (Reuters) - Antares Pharma Inc:

* Antares Pharma reports first quarter 2017 operating and financial results

* Q1 revenue $12 million versus I/B/E/S view $12.3 million

* Q1 loss per share $0.03

* Q1 earnings per share view $-0.03 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below